Where I see patients (2)
My reviews
Selected research
-
Niraparib and Abiraterone Acetate plus Prednisone in Metastatic Castration-resistant Prostate Cancer: Final Overall Survival Analysis for the Phase 3 MAGNITUDE Trial.
European urology oncology
-
Racial variation in the advanced prostate cancer genome.
Prostate cancer and prostatic diseases
-
A plain language summary of the results from the MAGNITUDE study assessing how effective and how safe niraparib and abiraterone acetate with prednisone is in patients with metastatic castration-resistant prostate cancer.
Future oncology (London, England)
5.0